Venus Remedies (BOM:526953) Short-Term Debt: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:526953 Venus Remedies Ltd BOM:526953
50 GF Score
Price ₹1,737.05
GF Value ₹525.67
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Venus Remedies Short-Term Debt?

Venus Remedies BOM:526953 +4.83% 50 Short-Term Debt is ₹0 Mil as of Jun. 2026. GuruFocus rates BOM:526953 with a GF Score™ of 50/100 and a GF Value™ of ₹525.67 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Venus Remedies's Short-Term Debt for the quarter that ended in Jun. 2026 was ₹0 Mil.

Venus Remedies's annual Short-Term Debt declined from Mar. 2024 (₹26 Mil) to Mar. 2025 (₹17 Mil) and declined from Mar. 2025 (₹17 Mil) to Mar. 2026 (₹0 Mil).

Venus Remedies Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Venus Remedies Short-Term Debt Related Terms

Venus Remedies Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Venus Remedies's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Venus Remedies Short-Term Debt Chart

Venus Remedies Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 41.66 36.14 26.46 16.93 0.00

Venus Remedies Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 13.40 0.00 0.00 0.00
BOM:526953
50GF Score
Venus Remedies Ltd BOM:526953
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of ₹0 Mil mean?
Venus Remedies (BOM:526953) has a Short-Term Debt of ₹0 Mil as of Jun. 2026.
Is Venus Remedies' Short-Term Debt too high?
Venus Remedies' current Short-Term Debt is ₹0 Mil. Overall, Venus Remedies has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Venus Remedies' Short-Term Debt compare to ZTS?
Venus Remedies' Short-Term Debt of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Drug Manufacturers company?
A good Short-Term Debt depends on the Drug Manufacturers industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Venus Remedies's current Short-Term Debt is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Venus Remedies stock overvalued right now?
Based on GuruFocus' analysis, Venus Remedies (BOM:526953) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹525.67, compared to a current price of ₹1,737.05 — trading 230.4% above its estimated fair value. The current Short-Term Debt is ₹0 Mil. Venus Remedies' overall GF Score™ is 50/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Venus Remedies (BOM:526953), the current Short-Term Debt is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Venus Remedies (BOM:526953) Overvalued in 2026?

Based on GuruFocus' analysis, Venus Remedies stock appears to be overvalued. The current stock price of ₹1,737.05 is trading 230.4% above its estimated GF Value™ of ₹525.67. GuruFocus considers Venus Remedies to be Significantly Overvalued.

Key valuation signals for BOM:526953:

  • Short-Term Debt: ₹0 Mil
  • GF Value™: ₹525.67 vs. price of ₹1,737.05 (230.4% above fair value)
  • GF Score™: 50/100 with 2 warning signs

No single metric tells the full story. See the BOM:526953 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Venus Remedies Business Description

Other Exchanges VENUSREM:India
Address Plot 51-52, Industrial Area, Phase 1, Panchkula, HR, IND, 134113
Venus Remedies Ltd is an Indian drug manufacturer. It is engaged in manufacturing and trading pharmaceutical products. The company produces biologically active food supplements which include food supplements are natural complexes containing minerals, vitamins, dietary fibers, extracts of medicinal herbs, amino acids and others.
50GF Score

Get the complete analysis for BOM:526953

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,737.05
Price
₹525.67
GF Value